323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
The Readout Loud
00:00
Lasker Awards and FDA Insights
In this chapter, the awarding of the Lasker Award highlights the significant contributions of three scientists in GLP-1 hormone research for obesity treatment. The discussion addresses misattributions of credit in the scientific community and the implications of the FDA's evolving approach to drug approval, particularly concerning a recently canceled advisory panel meeting. The chapter emphasizes the interconnectedness of scientific recognition and regulatory decisions in the pharmaceutical landscape.
Transcript
Play full episode
